Dian Zhong Luo
Liu J, Chen G, Dang Y, Li C, Luo D. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pac J Cancer Prev. 2014;15:2971-7 pubmed
..MALAT1 might be considered as a potential prognostic indicator and may be a target for diagnosis and gene therapy for PDAC. ..
Liu J, Peng W, Mo Y, Luo D. MALAT1-mediated tumorigenesis. Front Biosci (Landmark Ed). 2017;22:66-80 pubmed
..In this review, we first update on the role of MALAT1 in tumorigenesis and then discuss possible molecular mechanisms that underline the MALAT1-mediated gene regulation, leading to cancer invasion and metastasis. ..
Zhang Y, Chen W, Gan T, Zhang X, Xie Z, Ye Z, et al
. Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification. Sci Rep. 2017;7:5567 pubmed publisher
..These results indicate that HOXA11-AS plays pivotal roles in NSCLC and it can become a novel therapeutic direction for treating NSCLC. ..
Ren F, Yang H, He R, Lu J, Lin X, Liang H, et al
. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. BMC Cancer. 2018;18:12 pubmed publisher
..And the experiments in vivo and vitro will be conducted by our group to identify the specific mechanism of miR-34a in the progress and deterioration of HCC. ..
He R, Li X, Liang L, Xie Y, Luo D, Ma J, et al
. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model. BMC Cancer. 2017;17:655 pubmed publisher
..This evidence suggests that miR-542-5p is a potential tumor-suppressed miRNA in NSCLC, which has the potential to act as a diagnostic and therapeutic target of NSCLC. ..